Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Natural product-based therapy for B-cell cancer: Luteolin suppresses the expression of FOXP1 and inhibits Wnt/β-catenin signalling via up regulation of its target gene, 06/February/20145, 22.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that Luteolin, by increasing the expression of its target gene, it may inhibit the expression of FOXP1. Thereby, it may inhibit Wnt/β-catenin signalling that promotes tumor B-cell proliferation. Thus, pharmacological formulations encompassing “Luteolin or its analogues” can be used to inhibit B-cell cancer.
Amount: $ 300
Undisclosed information: How Luteolin suppresses the expression of FoxP1.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation